Senile dementia-Alzheimer's type and estrogen

Horm Metab Res. 1995 Apr;27(4):204-7. doi: 10.1055/s-2007-979941.

Abstract

Some reports have suggested the ameliorative effects of estrogens on clinical symptoms, such as short memory, in women suffering from senile dementia-Alzheimer's type, in vivo. The action mechanism of estrogen remains to be clarified, but 1) an anti-depressive effect, 2) improvement of cerebral blood flow, 3) direct stimulation of neuron, 4) development of gliacyte and 5) suppression of apolipoprotein E have been suggested. Some mechanisms may be combined, contributing to the beneficial effects on clinical symptoms.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Animals
  • Apolipoproteins E / metabolism
  • Depression / drug therapy
  • Estrogens / adverse effects
  • Estrogens / therapeutic use*
  • Female
  • Humans
  • Male
  • Vasodilation

Substances

  • Apolipoproteins E
  • Estrogens